FDA approves two new cancer treatments after fast tracked reviews

December 30th, 20180 The new cancer drugs Vitrakvi and Xospata were approved this past week after expedited reviews according to a report from CNN, with one expected to make an impact on the treatment options for childhood patients and the other for adults. Vitrakvi, which was approved this past Monday, was approved for both adult and pediatric cancer...